Research and Development

Researchers have discovered a protein signature which has proven to be highly predictive of leukaemia and has given rise to …

US patients suffering with tardive dyskinesia (TD) will see access to the first approved treatment in the country with the …

The urgency to find new antibiotics has led researchers into the mouths of Komodo dragons. In particular, the researchers were …

It may sound like the kind of science that would raise eyebrows rather than scientific interest but recent research has …

e-Therapeutics, a drug discovery company, announced that Dr. Raymond Barlow assumed the position of CEO at the beginning of April. …

The clinical trial is the fulcrum on which drug development and treatment hinges. Even with the advent of new technologies …

Bioverativ, a biotech company that develops therapies for rare blood disorders, announced the appointment of Tim Harris as Executive Vice …

Researchers at the Medical School at Harvard and MedUni Vienna’s Department of Ear, Nose and Throat Diseases have managed to …

Roche has announced that its drug Alecensa (alectinib) succeeded in meeting its primary endpoint in a Phase 3 trial assessing …

Zavante, a biotech company based in San Diego, has unveiled positive results from a recent Phase II/III trials that could …

It’s Friday, and medical device recalls have been the flavour of the week, with both GSK and Mylan having to …

Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of …

The Melsungen printer Faubel & Co. Nachfolger GmbH, which mainly produces booklet labels and custom labels for the pharmaceutical industry, …

Traditional approaches to patient therapies are increasingly showing their age inefficacy, but a powerful new gene editing technology is making …

Relay Therapeutics, a biotech firm launched in September 2016, has announced that Sanjiv K. Patel will be its CEO. Patel …